High-performance disintegrant with excellent swelling properties for rapid tablet disintegration
Superior swelling capacity in aqueous media for rapid and complete tablet disintegration.
Provides rapid tablet disintegration for immediate drug release and enhanced bioavailability.
Insoluble in water but swells rapidly, maintaining structural integrity during disintegration.
Excellent chemical stability and compatibility with various active pharmaceutical ingredients.
Parameter | Specification | Test Method |
---|---|---|
Appearance | White to off-white, odorless powder | Visual |
Identification | Complies with USP/EP standards | IR Spectroscopy |
pH (1% aqueous dispersion) | 6.0 - 8.5 | USP <791> |
Loss on Drying | ≤ 10.0% | USP <731> |
Residue on Ignition | 15.0 - 25.0% | USP <281> |
Heavy Metals | ≤ 20 ppm | USP <231> |
Degree of Substitution | 0.6 - 0.95 | USP Method |
Particle Size Distribution | ≥ 95% through 150 μm | USP <786> |
Bulk Density | 0.3 - 0.7 g/mL | USP <616> |
Tapped Density | 0.4 - 0.9 g/mL | USP <616> |
Swelling Volume | ≥ 4.5 mL/g | USP Method |
Microbial Limits | Total Aerobic Count: ≤ 1000 CFU/g Yeast & Mold: ≤ 100 CFU/g |
USP <61> |
Primary application as disintegrant for rapid tablet disintegration and drug release.
Suitable for direct compression processes with excellent flow and disintegration properties.
Compatible with wet granulation processes for improved tablet disintegration.
Enhances disintegration in chewable formulations for improved palatability.
Ideal for ODT formulations requiring rapid disintegration in the oral cavity.
Used in capsule formulations to improve drug dissolution and release characteristics.
Our Carmellose Calcium meets the highest international pharmaceutical standards and regulatory requirements.
United States Pharmacopeia
European Pharmacopoeia
Japanese Pharmacopoeia
Indian Pharmacopoeia
British Pharmacopoeia
Contact us today for quotes, samples, or technical support